Title : Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin.

Pub. Date : 2003 Apr

PMID : 12691916






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVE: Experiments on human erythropoietin (EPO) demonstrated that there is a direct relationship between the sialic acid-containing carbohydrate content of EPO, its circulating half-life, and in vivo bioactivity. Carbohydrates erythropoietin Homo sapiens
2 OBJECTIVE: Experiments on human erythropoietin (EPO) demonstrated that there is a direct relationship between the sialic acid-containing carbohydrate content of EPO, its circulating half-life, and in vivo bioactivity. Carbohydrates erythropoietin Homo sapiens
3 OBJECTIVE: Experiments on human erythropoietin (EPO) demonstrated that there is a direct relationship between the sialic acid-containing carbohydrate content of EPO, its circulating half-life, and in vivo bioactivity. Carbohydrates erythropoietin Homo sapiens
4 CONCLUSIONS: Increasing the sialic acid-containing carbohydrate content beyond the maximum found in EPO leads to a molecule with a longer circulating half-life and thereby an increased in vivo potency that can be administered less frequently. Carbohydrates erythropoietin Homo sapiens